6242 Stock Overview
Manufactures and sells supplement, cosmeceutical, and hygienic drink products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Li Kang Biomedical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$42.95 |
| 52 Week High | NT$60.40 |
| 52 Week Low | NT$42.50 |
| Beta | 0.27 |
| 1 Month Change | -0.46% |
| 3 Month Change | -1.26% |
| 1 Year Change | -27.08% |
| 3 Year Change | 32.98% |
| 5 Year Change | 29.01% |
| Change since IPO | -85.65% |
Recent News & Updates
Recent updates
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger
Apr 19
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?
Mar 09Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 09The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About
Jan 19We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt
Dec 29Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend
Dec 08Shareholder Returns
| 6242 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | 0.1% | -3.3% | 0.9% |
| 1Y | -27.1% | -19.7% | 28.9% |
Return vs Industry: 6242 underperformed the TW Personal Products industry which returned -19.5% over the past year.
Return vs Market: 6242 underperformed the TW Market which returned 28.5% over the past year.
Price Volatility
| 6242 volatility | |
|---|---|
| 6242 Average Weekly Movement | 2.0% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6242 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 6242's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 122 | n/a | www.likangbio.com |
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd.
Li Kang Biomedical Co., Ltd. Fundamentals Summary
| 6242 fundamental statistics | |
|---|---|
| Market cap | NT$1.37b |
| Earnings (TTM) | NT$81.99m |
| Revenue (TTM) | NT$573.36m |
16.7x
P/E Ratio2.4x
P/S RatioIs 6242 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6242 income statement (TTM) | |
|---|---|
| Revenue | NT$573.36m |
| Cost of Revenue | NT$180.61m |
| Gross Profit | NT$392.75m |
| Other Expenses | NT$310.76m |
| Earnings | NT$81.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.58 |
| Gross Margin | 68.50% |
| Net Profit Margin | 14.30% |
| Debt/Equity Ratio | 4.2% |
How did 6242 perform over the long term?
See historical performance and comparisonDividends
5.8%
Current Dividend Yield91%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 05:57 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Li Kang Biomedical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|